Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome
Frontiers in Nutrition · 23.07.2026 · 13
DOI: 10.3389/fnut.2026.1910233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 23.07.2026. Verfasst von Kuan-Chieh Tu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Chi Mei Hospital, Chiali, Taiwan. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Cardiovascular-kidney-metabolic (CKM) syndrome represents an interconnected disease continuum linking metabolic dysfunction, chronic kidney disease (CKD), and cardiovascular disease. Serum zinc deficiency (SZD) has been associated with adverse cardiovascular and renal outcomes; however, its association with CKM progression remains unclear.
Methods
This retrospective cohort study was conducted using the TriNetX. Adults with CKM stage 1 or 2 were enrolled in the study. SZD was defined as a serum zinc concentration < 70 μg/dL, while individuals with zinc concentrations between 70 and 120 μg/dL served as controls. After 1:1 matching, 74,245 patients were included in each group. The primary outcome was operational progression from CKM stage 1–2 to stage 3–4. Secondary outcomes included major adverse cardiovascular events, coronary artery disease, peripheral artery disease, atrial fibrillation, ischemic stroke, heart failure, advanced CKD, and all-cause mortality.
Results
Among 148,490 matching individuals, SZD was associated with a significantly increased risk of operational progression to CKM stage 3–4 compared with normal zinc status (HR, 1.36; 95% CI, 1.30–1.41; P < 0.001). SZD was also associated with increased risks of other secondary outcomes (all P < 0.0056 after Bonferroni correction).
Conclusion
Among patients with CKM stage 1–2, SZD was associated with a significantly increased risk of operational progression to CKM stage 3–4 and a broad spectrum of adverse cardiovascular, renal, and mortality outcomes. These findings suggest that SZD may represent an important marker of adverse CKM health and may help identify individuals at increased risk for CKM progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Chi Mei Hospital, Chiali, Taiwan.
- Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Nutrition and Health Sciences, Chang Jung Christian University, Tainan, Taiwan.
- Department of Hospitality Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
- Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
Zitieren
APA
Tu, K. C., Liu, M. Y., Hung, K. C., Lai, Y. C., Lai, C. C., Lin, Y. M., & Wu, J. Y. (2026). Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1910233
Vancouver
Tu KC, Liu MY, Hung KC, Lai YC, Lai CC, Lin YM, et al. Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1910233
BibTeX
@article{Tu2026,
author = {Tu, Kuan-Chieh and Liu, Mei-Yuan and Hung, Kuo-Chuan and Lai, Yi-Chen and Lai, Chih-Cheng and Lin, Yu-Min and Wu, Jheng-Yan},
title = {Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1910233}
}
EUVIMED